Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
OPHLF
Stock Latest News
Company Announcements
ONO’s Tirabrutinib Liver Study Completion: What It Means for OPHLF Investors
8d ago
OPHLF
Premium
Company Announcements
Real-World Data on Nivolumab Plus Chemo in Japanese Gastric Cancer: What Investors Should Watch
16d ago
BMY
Premium
Company Announcements
Ono’s ONO-4578 Breast Cancer Combo Clears Phase I Milestone, Setting Up the Next Investor Catalyst
29d ago
OPHLF
Premium
Company Announcements
ONO’s ONO-7018 Trial Termination: What It Means for OPHLF Investors
1M ago
OPHLF
Premium
Company Announcements
Ono’s Real-World Tirabrutinib Study in Taiwan Reaches Completion, Setting Up a New Catalyst for OPHLF
2M ago
OPHLF
Premium
Company Announcements
Ono’s Phase 3 Sapablursen Trial Targets Polycythemia Vera Upside for OPHLF Investors
2M ago
OPHLF
Premium
Company Announcements
ONO Pharmaceutical Details FY2025 Results and FY2026 Outlook with Focus on Pipeline and Core Metrics
2M ago
Premium
Company Announcements
Ono Pharmaceutical Delivers Strong FY 2025 Profits but Guides for Lower Revenue in FY 2026
2M ago
Premium
Pre-Earnings
Is OPHLF a Buy, Before Earnings?
2M ago
Premium
Company Announcements
ONO Pharmaceutical Nears Key Readout in Lung Cancer Combo Trial With Tagrisso
4M ago
OPHLF
Premium
Company Announcements
ONO Pharmaceutical Posts Strong Profit Growth in Q3 FY2025 and Maintains Full-Year Outlook
5M ago
Premium
Pre-Earnings
OPHLF Earnings this Week: How Will it Perform?
5M ago
Premium
Company Announcements
ONO Pharmaceutical Reports Strong Q2 Financial Performance with Revenue Growth
8M ago
Premium
Company Announcements
Ono Pharmaceutical’s Tirabrutinib Study: Key Insights for Investors
8M ago
OPHLF
Premium
Company Announcements
Ono Pharmaceutical’s Phase 3 Trial: A New Hope for PCNSL Treatment
8M ago
OPHLF
Premium
Company Announcements
Ono Pharmaceutical’s ONO-1110: A Promising Study for Interstitial Cystitis
8M ago
OPHLF
Premium
Company Announcements
ONO Pharmaceutical Advances Fibromyalgia Treatment with ONO-1110 Study
8M ago
OPHLF
Premium
Company Announcements
Ono Pharmaceutical’s ONO-4538 Study: A Potential Game-Changer for Richter’s Transformation
8M ago
OPHLF
Premium
Company Announcements
Bristol-Myers Squibb and ONO Pharmaceutical’s New Study on Nivolumab for NSCLC: What Investors Need to Know
8M ago
BMY
Premium
Company Announcements
ONO Pharmaceutical’s BRILLIANT Study: A Potential Breakthrough for Steroid-resistant Pemphigus
8M ago
OPHLF
Premium
Company Announcements
Ono Pharmaceutical’s ONO-1110: A Promising Treatment for Postherpetic Neuralgia
8M ago
OPHLF
Premium
Company Announcements
ONO Pharmaceutical’s ONO-2020: A Promising Alzheimer’s Study Update
8M ago
OPHLF
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
